InvestorsHub Logo
Followers 24
Posts 3519
Boards Moderated 0
Alias Born 05/24/2011

Re: None

Thursday, 07/24/2014 8:44:22 AM

Thursday, July 24, 2014 8:44:22 AM

Post# of 12606
From the Goldman Report .


Our current projections call for $2.6M in revenue this year, jumping to $10.5M in 2015 and $22.8M in 2016. Net profit should be recorded in 1H15, with EPS of $0.02 for the year. We note that these projections assume limited market penetration of just 30 clinics in the next 2 ½ years; the greater the penetration the greater the profits, and thus the valuation.

In our view, the BICX model is compelling given the top-line growth opportunities and its high operating margins. Our 6-12 month target of $0.40 is based upon a very reasonable 20x our 2015 EPS forecast of $0.02. We rate these shares Speculative Buy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News